Evidence map›Paper›PMID 24949692›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2014

[Clinical significance of ERCC1, RRM1 and TS in non-small cell lung cancer].

Pei Li, Xiaozheng Kang, Keneng Chen

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. [Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Pei LiKey laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department I of Thoracic Surgery, 
Peking University Cancer Hospital, Beijing 100142, China.
Xiaozheng KangKey laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department I of Thoracic Surgery, 
Peking University Cancer Hospital, Beijing 100142, China.
Keneng ChenKey laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department I of Thoracic Surgery, 
Peking University Cancer Hospital, Beijing 100142, China.
Ministry of Education · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCarcinoma, Non-Small-Cell LungDNA-Binding ProteinsEndonucleasesGene Expression Regulation, NeoplasticHumansLung NeoplasmsNucleoside-Phosphate KinaseRibonucleoside Diphosphate ReductaseTumor Suppressor ProteinsAntineoplastic AgentsDNA-Binding ProteinsdTMP kinaseEndonucleasesERCC1 protein, humanNucleoside-Phosphate KinaseRibonucleoside Diphosphate ReductaseRRM1 protein, humanTumor Suppressor Proteins

Identifiers

PMID24949692
PMCPMC6000105
OpenAlexW2440779346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.